Skip to content

Some of the 17 million Americans afflicted with major depressive disorder each year may soon receive a surprising new prescription from their clinician: Have fun on a virtual reality device.

Some of the 17 million Americans afflicted with major depressive disorder each year may soon receive a surprising new prescription from their clinician: Have fun on a virtual reality device.

A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.

A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.

Published on

Often misunderstood and undertreated, bipolar disorder has received close attention from Stanford Medicine clinicians and researchers for more than 30 years.

Often misunderstood and undertreated, bipolar disorder has received close attention from Stanford Medicine clinicians and researchers for more than 30 years.

Published on

Researchers who study long COVID say its debilitating symptoms are often misdiagnosed by clinicians and dismissed by employers or loved ones because so little is known about the new syndrome.

Researchers who study long COVID say its debilitating symptoms are often misdiagnosed by clinicians and dismissed by employers or loved ones because so little is known about the new syndrome.

Stanford Medicine doctors and researchers are modifying existing chatbots to perform well in a frontier of AI-enhanced medicine: the doctor-patient interaction.

Stanford Medicine doctors and researchers are modifying existing chatbots to perform well in a frontier of AI-enhanced medicine: the doctor-patient interaction.

A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.

A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.

A Q&A with a Stanford neuroscientist on dementia, healthy aging and memory loss — and how we can protect our brains in later life.

A Q&A with a Stanford neuroscientist on dementia, healthy aging and memory loss — and how we can protect our brains in later life.

Over the past decade, Stanford Medicine student Lillie Reed has dedicated her life and academic career to preventing violence and helping victims heal from the resulting trauma.  

Over the past decade, Stanford Medicine student Lillie Reed has dedicated her life and academic career to preventing violence and helping victims heal from the resulting trauma.  

Published on

Genome-wide association studies can lay the groundwork to more precisely assess a person’s risk for disease, detect diseases earlier, reveal a molecular understanding of how certain illnesses arise, and point to new therapeutic targets. 

Genome-wide association studies can lay the groundwork to more precisely assess a person’s risk for disease, detect diseases earlier, reveal a molecular understanding of how certain illnesses arise, and point to new therapeutic targets. 

For Christopher Lopez, currently a third-year medical student, the Stanford Medicine campus is more than just where he’s pursuing his MD-PhD degree -- it sits on the ancestral land of the Ohlone people.

For Christopher Lopez, currently a third-year medical student, the Stanford Medicine campus is more than just where he’s pursuing his MD-PhD degree -- it sits on the ancestral land of the Ohlone people.

Stanford Medicine's Jeffrey Goldberg believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.

Stanford Medicine's Jeffrey Goldberg believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.

Published on

Medicine has been the way of connecting both of Brian Smith's passions. “With medicine I could have the intellectual curiosity, but also the chance to talk with people and enjoy the human experience.”

Medicine has been the way of connecting both of Brian Smith's passions. “With medicine I could have the intellectual curiosity, but also the chance to talk with people and enjoy the human experience.”

Many social determinants of health can influence a patient’s risk, but Palaniappan and fellow researchers have noticed, from working with data from patients around the nation, that race is not among the most accurate or equitable.

Many social determinants of health can influence a patient’s risk, but Palaniappan and fellow researchers have noticed, from working with data from patients around the nation, that race is not among the most accurate or equitable.